Switzerland is world-renowned for its expertise in precision watchmaking and its excellence in medical technology. The eyeWatch implant, designed and developed by Lausanne-based Rheon Medical, perfectly embodies this alliance between tradition and innovation. It applies the principles of Swiss watchmaking to a revolutionary medical device for the treatment of glaucoma.
Inspiration from Swiss watchmaking
Swiss watchmaking is synonymous with high-precision mechanics, craftsmanship and innovation. These same qualities inspired the design of the eyeWatch implant, which is based on a fine regulation system that enables precise control of intraocular pressure (IOP) in glaucoma patients.
One of the major challenges of conventional glaucoma drainage devices is the lack of regulation of aqueous humor flow. This can lead to post-operative complications and difficult IOP adjustment. eyeWatch solves this problem with a technology inspired by watch adjustment mechanisms. In fact, a non-invasively adjustable magnetic disk can be used to modify fluid resistance, offering precise, patient-specific control.
Micromechanical precision in the service of medicine
Just as a watch movement requires absolute mastery of tolerances and the assembly of miniature parts, the design of eyeWatch demanded expertise in cutting-edge micromechanics. Rheon Medical designed every component of the device with extreme precision to ensure optimum reliability and efficiency in managing intraocular pressure.
The use of an adjustable magnetic system without invasive intervention is a first in the field of glaucoma surgery. This technology enables surgeons to adjust IOP simply by using an external magnet, without having to re-operate the patient. This level of control and adjustment is directly inspired by Swiss watchmaking innovations, where every adjustment must be infallibly precise.
Swiss innovation in the service of health
The link between eyeWatch and Swiss watchmaking doesn’t end with its concept. Switzerland is a country at the forefront of medical innovation, actively supporting research and development in the field of medical devices.
Rheon Medical has benefited from Swiss expertise in precision engineering and manufacturing, while collaborating with prestigious institutions such as EPFL (Ecole Polytechnique Fédérale de Lausanne). This synergy between science, technology and precision craftsmanship has resulted in a one-of-a-kind implant combining robustness, finesse and optimal functionality.
A major breakthrough in the treatment of glaucoma
Glaucoma is an eye disease that affects millions of people worldwide. It can lead to irreversible vision loss if not properly managed. With over 1,250 patients successfully treated to date, and increasing adoption by ophthalmology centers across Europe, eyeWatch represents a major advance in the management of this disease.
CE marking in Europe and FDA recognition as a “Breakthrough Device” in the United States attest to the innovative and transformative nature of this implant. By combining Swiss scientific rigor with technology inspired by precision watchmaking, eyeWatch redefines the standards of glaucoma treatment and improves patients’ quality of life.
When Swiss Precision Changes Lives
With eyeWatch, Rheon Medical proves that Swiss expertise is not limited to the manufacture of luxury watches. Applying the principles of micromechanics and watchmaking precision to a medical device opens up new prospects for ophthalmic surgery. This illustrates the immense potential of Swiss innovation in the healthcare sector.
Swiss precision no longer just measures time: it now helps preserve vision.